First Quarter Results On Form 6K
Filed with ASX · · 108 pages · English
In the deck
Story so far
Earlier from Mesoblast
- Successful Interim Futility Analysis In P3 Trial for GVHD
- MSB Japan Strategy Highlighted At Business Council Meeting
- Mesoblast Phase 2 Diabetic Kidney Disease Results Published
- Preliminary Final Report (Including Appendix 4E)
- MSB Strengthens US Patent Portfolio For Rheumatic Diseases
Later from Mesoblast
- MD Anderson and NIH Fund Trial Using Mesoblast Technologies
- Mesoblast And Mallinckrodt Enter Into Agreement
- Mesoblast Director Recognized For Cardiovascular Leadership
- Published Results Show MSB Cells Effective In RA Model
- Positive Nine Month RA Results For Mesoblast Cell Therapy
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast